Other
Obese Women
0
Pipeline Programs↗
0
Active Trials↗
1
Companies Involved↗
Obese Women is an early-stage landscape with 0 programs across 1 company. The most active players are Bayer.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
13
clinical trials
Completed10 · 77%
Unknown status2 · 15%
Withdrawn1 · 8%
Clinical Trials
Trial Activity
13 trials
High Dose Versus Low Dose Oxytocin for Augmentation of Delayed Labour in Obese Women
Completed·—·Phase 4·NCT03604874·202 enrolled
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
Completed·—·Phase 4·NCT03693599·1,200 enrolled
DPE Technique in Labor Epidural for Morbidly Obese Women
Completed·—·Phase 4·NCT03074695·141 enrolled
Accuracy of Ultrasound Markers Versus Biochemical Markers in Prediction of Ovarian Response in Obese Women Undergoing IVF/ICSI Treatment
Unknown status·—·N/A·NCT03684824·100 enrolled
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)